4Edward R, R. Michael Scott. Moyamoya: Epidemiology, Presentation, and Diagnosis[J]. Neurosurg Clin N Am, 2010, 21 (3): 543-551.
5Fukui M. 6uidelines for the diagnosis and treatment of spontaneous occlusionof the circle of Wii-lis ('moyamoya'disease). Research committee on spontaneous occlusion of the circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan[J]. el in?Neurol?Neurosurg, 1997, 99: $238-$240.
6Hashimoto N, Tominaga T, Miyamoto S. Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis) [J]. Neurol Med Chit (Tokyo), 2012, 52(5):245-266.
7Kelly ME, Bell-Stephens TE, Marks MP, et al. Progression of unilateral moyamoya disease: a clinical series[J]. Cerebrovasc Dis, 2006, 22 (2-3):109-115.
8Smith ER, Scott RM. Progression of disease in unilateral moyamoya syndrome[J]. Neurosurg Focus, 2008, 24 (2):E17.
9Nanba R, Tada M, Kuroda S, et al. Sequence analysis and bioinformatics analysis of chromosome 17q25 in familial moyamoya disease[J]. Childs Nerv Syst, 2005, 21 (1):62-68.
10Baba T, Houkin K, Kuroda S. Novel epidemiological features of moyamoya disease[J]. J Neurol Neurosurg Psychiatry,2007, 79 (8):900-904.
